Potential Effects of Cannabidiol as a Wake-Promoting Agent

Author(s): Eric Murillo-Rodriguez, Andrea Sarro-Ramirez, Daniel Sanchez, Stephanie Mijangos-Moreno, Alma Tejeda-Padron, Alwin Poot-Ake, Khalil Guzman, Elda Pacheco-Pantoja, Oscar Arias-Carrion.

Journal Name: Current Neuropharmacology

Volume 12 , Issue 3 , 2014

Become EABM
Become Reviewer

Abstract:

Over the last decades, the scientific interest in chemistry and pharmacology of cannabinoids has increased. Most attention has focused on Δ9-tetrahydrocannabinol (Δ9-THC) as it is the psychoactive constituent of Cannabis sativa (C. sativa). However, in previous years, the focus of interest in the second plant constituent with non-psychotropic properties, cannabidiol (CBD) has been enhanced. Recently, several groups have investigated the pharmacological properties of CBD with significant findings; furthermore, this compound has raised promising pharmacological properties as a wake-inducing drug. In the current review, we will provide experimental evidence regarding the potential role of CBD as a wake-inducing drug.

Keywords: Dopamine, hypothalamus, marijuana, sleep, sleepiness.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 12
ISSUE: 3
Year: 2014
Page: [269 - 272]
Pages: 4
DOI: 10.2174/1570159X11666131204235805
Price: $58

Article Metrics

PDF: 20